(2S)-1-[(1R,2R)-7-chloro-1-propan-2-yl-2,3-dihydro-1H-inden-2-yl]-N,N-dimethylpyrrolidine-2-carboxamide
C19H27ClN2O — CID 171443174
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S)-1-[(1R,2R)-7-chloro-1-propan-2-yl-2,3-dihydro-1H-inden-2-yl]-N,N-dimethylpyrrolidine-2-carboxamide
(2S)-1-[(1R,2R)-7-chloro-1-propan-2-yl-2,3-dihydro-1H-inden-2-yl]-N,N-dimethylpyrrolidine-2-carboxamide (PubChem CID 171443174) has the molecular formula C19H27ClN2O and a molecular weight of 334.89 g/mol. Its IUPAC name is (2S)-1-[(1R,2R)-7-chloro-1-propan-2-yl-2,3-dihydro-1H-inden-2-yl]-N,N-dimethylpyrrolidine-2-carboxamide.
Molecular Properties
| Compound Name | (2S)-1-[(1R,2R)-7-chloro-1-propan-2-yl-2,3-dihydro-1H-inden-2-yl]-N,N-dimethylpyrrolidine-2-carboxamide |
|---|---|
| PubChem CID | 171443174 |
| Molecular Formula | C19H27ClN2O |
| Molecular Weight | 334.89 g/mol |
| Exact Mass | 334.18 |
| IUPAC Name | (2S)-1-[(1R,2R)-7-chloro-1-propan-2-yl-2,3-dihydro-1H-inden-2-yl]-N,N-dimethylpyrrolidine-2-carboxamide |
| SMILES | CC(C)[C@@H]1c2c(Cl)cccc2C[C@H]1N1CCC[C@H]1C(=O)N(C)C |
| InChI | InChI=1S/C19H27ClN2O/c1-12(2)17-16(11-13-7-5-8-14(20)18(13)17)22-10-6-9-15(22)19(23)21(3)4/h5,7-8,12,15-17H,6,9-11H2,1-4H3/t15-,16+,17-/m0/s1 |
| InChIKey | UUPHTEJHZGDFKP-BBWFWOEESA-N |
| XLogP | 3.56 |
| TPSA | 23.55 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 23 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 334.89 |
| LogP ≤ 5 | 3.56 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 2 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171443174 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.